-
Medtronic Sprint Fidelis Wire Leads Fracturing In Defibrillators May Have Caused Five Deaths
Events Leading Up To October 2007 FDA Recall Include A Little Noticed March 2007 "Dear Doctor" Letter And July 2007 Medical Journal Article About Model 6949 (Posted by Tom Lamb at DrugInjuryWatch.com) An October…
-
How Should Drug Companies And Their Ad Agencies Respond To Safety Signals?
Two Perspectives On How Emerging Drug Safety Situations Should Be Handled Going Forward (Posted by Tom Lamb at DrugInjuryWatch.com) The September 1, 2007 edition of Pharmaceutical Executive starts with the piece "From the Editor:…
-
Health Canada Provides 2007 Update On Reports Of Suspected Meridia Adverse Reactions
Meridia Can Increase Blood Pressure And Heart Rate Leading To Possible Serious Cardiovascular Problems (Posted by Tom Lamb at DrugInjuryWatch.com) The Canadian Adverse Reaction Newsletter (CARN) released in October 2007 (Volume 17, Issue 4)…
-
FDA Updates Exjade Adverse Drug Reaction Numbers In Its First Drug-Safety Newsletter
FDA Post-Marketing Safety Review Adds Liver Problems To Previous Reports Of Kidney Failure Associated With Exjade (Posted by Tom Lamb at DrugInjuryWatch.com) In the first edition of FDA Drug Safety Newsletter (Volume 1, Number…
-
Sleep Disorder Narcolepsy Drug Provigil Associated With Serious Skin Reactions
FDA Links Cephalon’s Provigil To Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, And Erythema Multiforme (Posted by Tom Lamb at DrugInjuryWatch.com) According to the Fall 2007 FDA Drug Safety Newsletter (Volume 1, Number 1), which was…
